miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma

Biomarkers to guide the clinical treatment of patients with renal cell carcinoma (RCC) are not yet routinely available. MicroRNAs (miRNAs) have been demonstrated to serve as biomarkers for a number of types of cancer. Based on a previous study by this group, we hypothesize that several highly differ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncol Lett
Prif Awduron: Chen, Xuanyu, Lou, Ning, Ruan, Anming, Qiu, Bin, Yan, Yun, Wang, Xuegang, Du, Quansheng, Ruan, Hailong, Han, Weiwei, Wei, Haibin, Yang, Hongmei, Zhang, Xiaoping
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2018
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6036413/
https://ncbi.nlm.nih.gov/pubmed/30008851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8874
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg